EP. 1: Episode 1 - The Prevalence of Comorbid Cardiometabolic Disorders in the US
Watch
EP. 2: Episode 3 - The Diversity of Patient Populations
EP. 3: Episode 2 - The Challenges of Disease Management: Clinician and Provider Perspectives
EP. 4: Episode 4 - The Link Between Diabetes and Cardiovascular Disease
EP. 5: Episode 5 - Setting the Tone: Current Therapeutic Goals
EP. 6: Episode 6 - Diabetes and the Burden of Disease
EP. 7: Episode 7 - The Complex Equation of Management
EP. 8: Episode 8 - A Diverse Patient Population and Its Challenges
EP. 9: Episode 9 - Current Challenges and Gaps in Patient Care
EP. 10: Episode 10 - Drivers of Cost in Cardiometabolic Management
EP. 11: Episode 11- Future Outlook on Preventive Care
EP. 12: Episode 12- Comparing Current Healthcare Spending to Patient Outcomes
EP. 13: Episode 13- Current Developments of Pharmacotherapeutic Spending
EP. 14: Episode 14- Recent Trends in the Epidemiology of Cardiometabolic Conditions
EP. 15: Episode 15- Assessing the Factors at Increased Risk for Cardiometabolic Events
EP. 16: Episode 16- Exploring the Benefits and Limitations of Available Agents
EP. 17: Episode 17 - Evolving Guidelines for the Treatment of Cardiometabolic Events
EP. 18: Episode 18 - Impact of Obesity on Cardiometabolic Events
EP. 19: Episode 19 - - Initiatives Aim to Control Cardiometabolic Events
EP. 20: Episode 20 - Pharmacotherapeutic Initiatives
EP. 21: Episode 21 - Expectations for Newly Developing Agents
EP. 22: Episode 22 - Antiplatelet Agents Explored
EP. 23: Episode 23 - The Affordable Care Act and Healthcare Reform
EP. 24: Episode 24 - Accountable Care Organizations
EP. 25: Episode 25 - Closing Remarks
